• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, September 17, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Global funding for adolescent health misses the target

Bioengineer by Bioengineer
August 10, 2018
in Health
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Even though adolescents make up 26 percent of the population in developing countries, their health claimed a meager 1.6 percent of global development assistance between 2003 and 2016, according to a newly published study led by researchers at Harvard Medical School.

The findings, which appear Aug. 10 in JAMA Network Open, reveal that very little money went to projects geared toward some of the most serious causes of poor adolescent health, such as anemia, injuries and depressive disorders. Similarly, little funding went to support health projects for adolescents known to yield high return on investment, the study found.

While the percentage of funding for adolescent health increased from 1.3 percent to 2.2 percent during the 2003-2016 timeframe, the relatively small proportion of spending destined for adolescent health–even at its highest levels–suggests that adolescent health does not command the attention it deserves from the global community, the researchers said.

"Adolescence is a phase of rapid physical, cognitive and emotional growth that shapes adult health for decades to come," said study senior author Chunling Lu, assistant professor of global health and social medicine at Harvard Medical School. "Considering how important young people are for the future well-being and economic development of low- and middle-income countries, international donors need to reconsider both the levels and the patterns of investments that they are making."

The largest amount of development funding for adolescent health was targeted at HIV and AIDS, followed by interpersonal violence, tuberculosis and diarrheal disease, all of which are among the leading causes of illness and disability for adolescents. However, other leading causes of disease burden in the developing world, including anemia, road injuries and depressive disorders, were largely overlooked by donors, the researchers found. Seriously underfunded areas such as mental health and injury prevention are also known to yield particularly high cost-benefit ratios, the investigators said.

A growing body of research has shown just how critical the growth, health and development that occur during adolescence are to setting the stage for lifelong health. As a result, adolescent health is now a priority in many new international planning guidelines, the researchers said. The rapidly increasing population of adolescents currently growing up in developing countries further demands greater investment in adolescent health, the team added.

"The international donor community has been 'asleep at the wheel' in failing to keep pace with changing demography and health needs," said co-investigator George Patton, of the Centre for Adolescent Health at the Murdoch Children's Research Institute in Melbourne, Australia. "Despite supporting the United Nations' 'Global Strategy for Women's, Children's and Adolescents Health,' international investment from agencies have so far failed to make serious investments in the world's young people."

To determine whether spending patterns were aligned with these new priorities, the researchers assessed how much development assistance has been disbursed to projects for adolescent health in 132 developing countries between 2003 and 2015. For the purposes of the study, adolescents were defined as those between the ages of 10 and 24.

The findings suggest that current spending levels are not sufficient to meet the adolescent health needs of many low- and middle-income countries, the researchers said. Lu noted that a few simple steps could help to greatly improve the situation: While investments in HIV/AIDS should undoubtedly be maintained, donors should also consider investments in other areas, especially those that would greatly lessen the burden of disease among adolescents with cost-effective interventions. In addition, for places and types of interventions where cost effectiveness data are not available, there is an acute need for investment in research to assess the impact of interventions. Evidence from such studies would be invaluable in guiding future resource allocations for adolescent health in comparison to other areas of need, said Lu, who is also an assistant professor of medicine at Harvard-affiliated Brigham and Women's Hospital.

"Adolescence is a critical time of life to build the health of the next generation," said Lu. "Our study shows that taking adolescent health to scale will require greater allocation of development funds for adolescent health in general and better targeting toward the major causes of disease burden among adolescents. It's an investment well worth making."

###

This study was led by Zhihui Li, a doctoral candidate at the Harvard T.H. Chan School of Public Health.

The research was supported the Brigham and Women's and the Ronda Stryker Funds at Harvard Medical School.

Media Contact

Ekaterina Pesheva
[email protected]
617-432-0441
@HarvardMed

http://hms.harvard.edu

Share12Tweet7Share2ShareShareShare1

Related Posts

Evaluating Sickle Cell Gene Therapy Costs for Medicaid

September 17, 2025

Covariation MS Reveals Protein Regulating Cysteine Catabolism

September 17, 2025

Alcohol-Induced Death Rates in the General Population Nearly Double from 1999 to 2024

September 17, 2025

High-Intensity Interval Training Enhances Cocaine Aversion in Adolescent Lab Animals, Study Finds

September 17, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    155 shares
    Share 62 Tweet 39
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    117 shares
    Share 47 Tweet 29
  • Physicists Develop Visible Time Crystal for the First Time

    67 shares
    Share 27 Tweet 17
  • Scientists Achieve Ambient-Temperature Light-Induced Heterolytic Hydrogen Dissociation

    48 shares
    Share 19 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Analyzing Genetic Traits in Bangladesh’s Aman Rice Varieties

Gaza’s Temporary “Medical Points” Provide Care to 117 Patients Daily with Minimal Staff

Evaluating Sickle Cell Gene Therapy Costs for Medicaid

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.